The Global Stem Cell Partnering 2010-2018: Deal trends, players,
financials and forecasts report provides comprehensive understanding and
unprecedented access to the stem cell partnering deals and agreements
entered into by the worlds leading healthcare companies. This report
provides details of the latest Stem Cell agreements announced in the
life sciences since 2010.

The report provides a detailed understanding and analysis of how and why
companies enter Stem Cell partnering deals. These deals tend to be
multicomponent, starting with collaborative R&D, and proceed to
commercialization of outcomes.

The report takes the reader through a comprehensive review of Stem Cell
deal trends, key players, top deal values, as well as deal financials,
allowing the understanding of how, why and under what terms, companies
are entering Stem Cell partnering deals.